Newer Issues in Mesothelioma Chemotherapy

This publication has 15 references indexed in Scilit:

• Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
  Journal of Clinical Oncology, 2005
• Chemotherapy for malignant pleural mesothelioma: past results and recent developments
  Lung Cancer, 2004
• Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
  Annals of Oncology, 2004
• Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
  Journal of Clinical Oncology, 2003
• A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
  British Journal of Cancer, 2002
• Oxaliplatin and Raltitrexed in the Treatment of Inoperable Malignant Pleural Mesothelioma: Results of a Pilot Study
  Tumori Journal, 2001
• Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B
  Lung Cancer, 2001
• Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems
  Thorax, 2000
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group B
  Chest, 1998